Pipeline2022-08-11T17:06:33+00:00

Publications

Fibroblast activation protein inhibitor-PET/CT in lung cancer: a prospective single-center study with histopathological correlation of fibroblast activation protein expression

Takashi Hiroshima, Toru Kimura, Tadashi Watabe, Takahiro Matsui, Akiisa Omura, Yusuke Sugiura, Hideki Nagata, Kenji Kimura, Eriko Fukui, Takashi Kanou, Naoko Ose, Mitsuaki Tatsumi, Frederik L Giesel, Eiichi Morii, Yasushi Shintani Background: Recent studies have demonstrated the utility of fibroblast activation protein inhibitor (FAPI)-positron emission [...]

31, Jul 2026|Publications|

[18F]FAPI-74 PET for Preoperative Assessment of Peritoneal Dissemination in Ovarian Cancer: A Case Series with Surgical and Histopathological Correlation

Aasa Shimizu, Tadashi Watabe, Frederik L Giesel, Yuriko Mori, Keita Asano, Yusaku Shimizu, Sadahiro Naka, Takashi Kamiya, Daisuke Katayama, Shinichiro Watanabe, Hiroki Kato, Kayako Isohashi, Mitsuaki Tatsumi, Noriyuki Tomiyama, Yasuto Kinose, Tadashi Iwamiya, Shinya Matsuzaki, Kenjiro Sawada, Michiko Kodama Background/objectives: Accurate preoperative assessment of peritoneal [...]

29, Jun 2026|Publications|

[68Ga]Ga-FAPI-46 PET enables non-invasive monitoring of hepatic fibrosis progression during TGF-β inhibition

Yeeun Kim, Myeongguk Jeong, Go-Eun Choi, Hyeokjin Kwon, Hyun Jin Yoon, Young-Jin Jeong, Ji Yong Park, Do-Young Kang, Sungmin Jun Abstract Hepatic fibrosis, a precursor to cirrhosis and hepatocellular carcinoma, affects millions worldwide but lacks effective therapies and depends on invasive liver biopsies for [...]

2, Jun 2026|Publications|

Safety of [68Ga]Ga-FAPI-46 PET/CT including hemodynamic measurements and patient-reported outcomes in cancer patients

Morten Bentestuen, Camilla Sylvest, Svend B Jensen, Lara R Soro, Aage Knudsen, Morten Ladekarl, Ole Thorlacius-Ussing, Wolfgang P Fendler, Helle D Zacho Introduction aim: Fibroblast activation protein inhibitor (FAPI) has demonstrated promising oncological diagnostic performance. Although no adverse events (AEs) have been previously reported, [...]

3, May 2026|Publications|

A 3D co-culture model with fibroblast-restricted FAP expression for cancer therapy using [212Pb]Pb-FAPI-46

Sandra K Kristiansen, Nurtene Dernjani, Øyvind S Bruland, Nina Frederike J Edin, Asta Juzeniene No Abstract Available View Publication

18, Apr 2026|Publications|

Ensuring enantiomeric consistency in FAPI radiopharmaceuticals

Magdalena Staniszewska, Ralph Hübner, Camilla Locatelli, Douglas Howard, Matilde Forni, Francis Man, Bent Wilhelm Schoultz, Syed Nuruddin, Ingrid Sofie Norberg-Schulz Hagen, Sherly Mosessian, Ken Herrmann, Valeska von Kiedrowski, Katharina Lückerath Abstract: Background: Enantiomeric composition may impact binding and potentially performance of a drug product but [...]

28, Feb 2026|Publications|
Go to Top